Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Improving Mitral Repair for Functional Mitral Regurgitation

A legfontosabb adatok

Ki végzi
Emory University
Hol
Atlanta (Egyesült Államok)Mind a 3 helyszín megnézése
Azonosító
Állapot
Leállítva
Résztvevők
34 fő vett részt
Kezdés
2018. márc. 20.
Befejezés
2023. dec. 31.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
A vizsgált kezelések
  • Undersizing Mitral Annuloplasty
  • Papillary Muscle Approximation
A regiszteradat frissítve
2025. január 16.
Miért állt le
The study was terminated due to poor enrollment during COVID-19, which also hindered postoperative testing. With insufficient enrollment to meet trial goals, funds were redirected to animal studies on the same clinical issues.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 13 feltétel megnézéseKevesebb

Ki vehet részt

  • Mitral regurgitation of moderate or greater severity, as defined by the guidelines of the American Society of Echocardiography (via a transthoracic echo)
  • Cardiomyopathy of ischemic or non-ischemic origins, with or without the need for coronary revascularization
  • Concomitant right-sided valve repair or replacement (i.e. patients requiring concomitant tricuspid procedures)
  • Able to sign informed consent and release of medical information forms

Ki nem vehet részt

  • Prior mitral valve repair
  • ST-segment elevation myocardial infarction within 14 days before inclusion in this study
  • Congenital heart disease, except patent foramen ovale (PFO) or atrial septal defect (ASD)
  • Recent history of psychiatric disease that is likely to impair compliance with the study protocol, in the judgement of the investigator
  • Chronic renal insufficiency defined by creatinine ≥ 3.0 or chronic renal replacement therapy, who are contraindicated for cardiac surgery
  • Any evidence of structural (chordal or leaflet) mitral lesions
  • Contraindication for cardiopulmonary bypass
  • Clinical signs of cardiogenic shock at the time of randomization
  • Pregnancy at the time of randomization

Helyszínek itt: Egyesült Államok

  • Emory St. Joseph's HospitalAtlanta, Egyesült Államok
  • Emory University HospitalAtlanta, Egyesült Államok
  • Emory University Hospital MidtownAtlanta, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The investigators are interested in determining the best surgical technique to correct functional mitral regurgitation, as there is currently not one technique that is established to work better than the other.

A teljes eredeti leírásKevesebb

The technique used in current clinical practice is undersizing mitral annuloplasty (UMA), in which a prosthetic ring is implanted onto the mitral valve to correct the leakage. Though widely adopted, durability of the repair is less, as 58% of the patients present with recurrent FMR within 2 years. There are no specific algorithms to predict who might have UMA failure, but research indicates that some geometric indices might be strong predictors. The investigators are interested in testing the hypothesis that, elevated lateral inter-papillary muscle separation (IPMS) is a predictor of post-UMA recurrence of FMR at 12 months. In the first part of this study, the study team will measure lateral IPMS before surgery and relate to post-surgery FMR severity at discharge/30 days, 6 months and 12 months.

A relatively newer technique is papillary muscle approximation (PMA), in which a suture draws together the two muscles that connect the mitral valve to the heart muscle prior to performing UMA. This reduces the lateral inter-papillary muscle separation (IPMS) and is expected to improve the durability of UMA. In the second part of this study, the investigators will perform PMA and UMA together and determine if FMR severity is reduced at discharge/30 days, 6 months and 12 months.

A vizsgálat 3 csoportja

  • UMA (Group 1)Egyéb csoport

    Participants in the UMA group will receive an undersizing mitral annuloplasty (UMA).

    Kezelés: Undersizing Mitral Annuloplasty

  • UMA + PMA (Group 2)Egyéb csoport

    Participants in the UMA + PMA group will receive an undersizing mitral annuloplasty (UMA) with papillary muscle approximation (PMA).

    Kezelés: Undersizing Mitral Annuloplasty és Papillary Muscle Approximation

  • Retrospectively identified patientsNincs vizsgálati kezelés, összehasonlításként

    Retrospectively identified patients, who already underwent the standard of care surgery for the lesion of interest at Emory, within 6 months (± 1 month) after the date of their surgery, and are suitable for recruitment to the study for their post-operative research.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2025. január 16.